WASHINGTON (Reuters) - An experimental vaccine against multiple sclerosis appears to be safe and may produce beneficial changes in patients’ brains and immune systems, Canadian researchers reported on Monday.Some patients appeared to have fewer immune cells attacking their nerves, a hallmark of MS, the researchers report in the Archives of Neurology. They also appeared to have fewer lesions in their brains.
